The Wall Street Journal: Abbott Laboratories under SEC and FTC investigation over baby-formula business


The Securities and Exchange Commission and Federal Trade Commission are investigating Abbott Laboratories’ baby-formula business, the company said.

The SEC’s enforcement division sent a subpoena to Abbott ABT, +0.62% in December requesting information about its powder infant-formula business and related public disclosures, the company said Friday in a securities filing.

This article was originally published by Read the original article here.

Previous articleMeta performance reviews could presage wave of employee departures: report
Next article: Gold futures post a third straight weekly loss


Please enter your comment!
Please enter your name here